Civco Holding may soon own medical device design firm Colorado MEDtech. The two companies announced March 13 the signing of a definitive agreement for the sale of the Boulder, CO, company for $62.5 million. KRG Capital Partners and its affiliated funds
Civco Holding may soon own medical device design firm Colorado MEDtech. The two companies announced March 13 the signing of a definitive agreement for the sale of the Boulder, CO, company for $62.5 million. KRG Capital Partners and its affiliated funds control Civco Holding. Subject to shareholder approval and due diligence, the transaction is expected to close by June 30. The agreement calls for Colorado MEDtech to operate as a private corporation. It will continue developing and manufacturing equipment for the ultrasound and minimally invasive OEM and end-user markets.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.